Cell Therapy Market Analysis and Forecast to 2031: By Therapy Type (Autologous, Allogenic), Therapeutic Area (Malignancies, Autoimmune Disorders, Dermatology, Others), End-Use (Hospitals, Clinics, Academic, Others), and Region

Cell therapy is a type of treatment that uses living cells to treat a disease or condition. The cells can be from the patient’s own body, or they can be from a donor. Cell therapy is also called cellular therapy, cell transplantation, or regenerative medicine.

Key Trends

The major factors driving the growth of this market are the increasing prevalence of cancer and chronic diseases, and the growing demand for personalized medicine.

However, the high cost of cell therapy treatments and the lack of skilled professionals are the major factors restraining the growth of this market.

Key Drivers

The key drivers of the cell therapy market are the increasing incidence of cancer, the rise in the aging population, and the growing demand for minimally invasive treatments.

The aging population is also a major driver of the cell therapy market, as the risk of developing cancer increases with age.

The demand for minimally invasive treatments is also growing, as patients seek to avoid the side effects of traditional cancer treatments such as chemotherapy and radiation therapy.

Restraints & Challenges

One of the key restraints in the cell therapy market is the lack of standardized protocols for manufacturing and quality control of cell-based products.

In addition, the high cost of cell therapy products is a major challenge in the market. Cell therapy products are typically made from autologous cells, which are expensive to procure and process.

Market Segments

The cell therapy market is segmented by therapy type, therapeutic area, end-user, and region. By therapy type, the market is classified into autologous, and allogenic. On the basis of therapeutic area, it is bifurcated into malignancies, autoimmune disorders, dermatology, and others. Based on end-use, it is divided into hospitals, clinics, academic, and others. Region-wise, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

Key Players

The global cell therapy market includes players such as Allosource, Cells for Cells, Holostem Terapie Avanzate Srl, JCR Pharmaceuticals Co Ltd, Kolon Tissuegene Inc, Medipost Co Ltd, Mesoblast Ltd, Nuvasive Inc, Osiris Therapeutics, Inc, Stemedica Cell Technologies Inc, and others.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Cell Therapy Market Outlook
3.1. Cell Therapy Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Global Cell Therapy Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Global Cell Therapy Market
4.3. Economic Impact Analysis

Chapter 5. Cell Therapy Market by Therapy Type
5.1. Market Overview
5.2. Autologous
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Allogenic
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Cell Therapy Market by Therapeutic Area
6.1. Market Overview
6.2. Malignancies
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Autoimmune Disorders
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Dermatology
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.5. Others
6.5.1. Market Size and Forecast, 2021-2031 ($Million)
6.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Cell Therapy Market by End-Use
7.1. Market Overview
7.2. Hospitals
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Clinics
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Academic
7.4.1. Market Size and Forecast, 2021-2031 ($Million)
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.5. Others
7.5.1. Market Size and Forecast, 2021-2031 ($Million)
7.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. Cell Therapy Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.2.3. North America Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.2.4. North America Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.2.5. North America Cell Therapy Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.2.6.2. The U.S. Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.2.6.3. The U.S. Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.2.7. Canada
8.2.7.1. Canada Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.2.7.2. Canada Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.2.7.3. Canada Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.2.8. Mexico
8.2.8.1. Mexico Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.2.8.2. Mexico Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.2.8.3. Mexico Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.3.3. Europe Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.4. Europe Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.5. Europe Cell Therapy Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.3.6.2. Germany Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.6.3. Germany Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.3.7. France
8.3.7.1. France Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.3.7.2. France Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.7.3. France Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.3.8. U.K.
8.3.8.1. U.K. Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.3.8.2. U.K. Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.8.3. U.K. Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.3.9. Spain
8.3.9.1. Spain Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.3.9.2. Spain Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.9.3. Spain Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.3.10.2. Italy Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.10.3. Italy Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.3.11.2. Rest of Europe Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.11.3. Rest of Europe Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Cell Therapy Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.4. Asia-Pacific Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.4.5. Asia-Pacific Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.4.6.2. China Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.6.3. China Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.4.7. India
8.4.7.1. India Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.4.7.2. India Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.7.3. India Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.4.8. Japan
8.4.8.1. Japan Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.4.8.2. Japan Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.8.3. Japan Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.4.9.2. South Korea Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.9.3. South Korea Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.4.10.2. Rest of APAC Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.10.3. Rest of APAC Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.5.3. Rest of the World Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.5.4. Rest of the World Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.5.5. Rest of the World Cell Therapy Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.5.6.2. Latin America Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.5.6.3. Latin America Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.5.7.2. Middle East Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.5.7.3. Middle East Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

8.5.8. Africa
8.5.8.1. Africa Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.5.8.2. Africa Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.5.8.3. Africa Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.5.9. Rest of LAMEA
8.5.9.1. Rest of LAMEA Cell Therapy Market Size and Forecast by Therapy Type, 2021-2031, ($Million)
8.5.9.2. Rest of LAMEA Cell Therapy Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.5.9.3. Rest of LAMEA Cell Therapy Market Size and Forecast by End-Use, 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Allosource
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Cells for Cells
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product Offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Holostem Terapie Avanzate Srl
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product Offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. JCR Pharmaceuticals Co Ltd
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product Offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Kolon Tissuegene Inc
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product Offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Medipost Co Ltd
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product Offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Mesoblast Ltd
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product Offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Nuvasive Inc
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product Offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Osiris Therapeutics, Inc
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product Offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Stemedica Cell Technologies Inc
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product Offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

Key Players
  • Allosource
  • Cells for Cells
  • Holostem Terapie Avanzate Srl
  • JCR Pharmaceuticals Co. Ltd.
  • Kolon Tissuegene Inc.
  • Medipost Co Ltd.
  • Mesoblast Ltd.
  • Nuvasive Inc.
  • Osiris Therapeutics, Inc.
  • Stemedica Cell Technologies Inc.
Market Segmentation

By Therapy Type

  • Autologous
  • Allogeneic

By Therapeutic Area

  • Malignancies
  • Autoimmune Disorders
  • Dermatology
  • Others

By End-Use

  • Hospitals
  • Clinics
  • Academic
  • Others

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Oligonucleotide synthesis is the process of making oligonucleotides,…
T-cell therapy is a type of immunotherapy that…
Bioremediation technology is the use of living organisms…
Veterinary services are medical and surgical care for…
A nutraceutical is a food or food product…
Diabetic Gastroparesis is a serious complication of diabetes…
Synthetic biology is the design and construction of…
Crohn’s disease is a type of inflammatory bowel…
Diabetic neuropathy is a type of nerve damage…
The Empty Capsules Market is growing rapidly as…